'Can I stop my tablets Doc?: predicting drug free remission in rheumatoid arthritis'
The past two decades have witnessed a revolution in rheumatoid arthritis (RA) outcomes, with remission now a realistic and achievable target for many patients. However, this heralds a new dilemma increasingly encountered in routine clinical practice: how best to manage expensive and potentially toxic immunosuppressive therapy in such individuals?
I will present our clinical trial data to support a composite biomarker capable of predicting drug-free remission in established RA. The concept of drug-free remission will also be explored from a patient perspective, together with ongoing and future avenues of research to better understand the pathoimmunological processes underpinning RA flare.
29 April 2019, 12:00 (Monday, 1st week, Trinity 2019)
Kennedy Institute of Rheumatology, Headington OX3 7FY
Bernard Sunley Lecture Theatre
Dr Kenneth Baker (NIHR University of Newcastle)
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)
Prof Chris Buckley (Kennedy Institute of Rheumatology)
Organiser contact email address:
Members of the University only